Complications of pyelonephritis

Complications of the acute inflammatory process

Acute pyelonephritis can lead to a number of life-threatening conditions requiring immediate intervention. Conventionally, three basic structural complications are distinguished:

• Papillary necrosis (death of renal papillae).
• Pyonephrosis (massive purulent melting of the renal tissue).
• Perinephric abscess (formation of a localized abscess in the perirenal tissues).

The risk of an unfavorable outcome in the acute form is primarily associated with the spread of infection beyond the urinary system. The most dangerous is the generalization of the process, which manifests as the development of urosepsis and septic (bacteriotoxic) shock. Furthermore, the progression of the disease to the stage of pyonephrosis or extensive papillary necrosis can provoke acute renal failure.

Purulent-destructive processes in obstruction

The most severe course of the disease is observed in the obstructive form of pyelonephritis. Impaired adequate urine outflow (pathway obstruction) often leads to the combined development of structural pathology and infection, resulting in hydronephrosis combined with chronic inflammation.

In severe obstructive courses, purulent-destructive processes naturally develop in the parenchyma:

1. Apostematous nephritis.
2. Renal carbuncle.
3. Renal abscess.
4. Renal papillary necrosis.

If purulent inflammation progresses and extends beyond the organ's capsule (as a continuation of a carbuncle or abscess), the process turns into paranephritis—purulent involvement of the perirenal adipose tissue. Such complications are also typical for hematogenous seeding of infection (e.g., in staphylococcal sepsis or endocarditis). In young children, it is precisely these severe purulent-destructive forms that account for the main percentage of mortality.

Outcomes of chronic pyelonephritis

The chronic form of the disease is a progressive tubulointerstitial inflammation that can have a relapsing or latent course. The prolonged process naturally leads to the destruction of the pelvicalyceal system and subsequent replacement of the functioning parenchyma with connective tissue, forming nephrosclerosis (renal shrinkage).

The main cause of death in patients with the chronic process is relentlessly progressive chronic kidney disease (uremia) developing against the background of bilateral renal shrinkage.

The second major mortality factor is nephrogenic arterial hypertension. Long-standing high blood pressure leads to fatal cardiovascular events, such as acute heart failure and strokes.

Complication prevention and rehabilitation

Despite the severity of potential complications, the overall prognosis for life is assessed as favorable. To prevent the acute form from becoming chronic and to avoid relapses, comprehensive rehabilitation is applied:

• Step-down uroantiseptic therapy: prescribed after the main course of antibiotics for a period of 1 to 3 months. Nitrofuran derivatives, non-fluorinated quinolones, or oxyquinolines are used until complete urine sterilization is achieved.
• Phytotherapy: herbal preparations with diuretic, antiseptic, and regenerative effects.
• Balneotherapy: course drinking of alkaline mineral waters.
• Clinical dispensary follow-up: strict patient monitoring for at least 3 years with mandatory monthly urinalysis control.

Class and exam questions

What else to study on this topic

• Step-down uroantiseptic therapy: drugs, dosages, and discontinuation criteria
• Pathogenesis of nephrosclerosis in chronic tubulointerstitial inflammation
• Features of antibacterial therapy when intracellular pathogens are detected
• Primary chronic pyelonephritis: specifics of the latent course
• The role of urodynamic disorders and vesicoureteral reflux in the chronization of the process

Other topics in the "Additional Topics" section

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.